The mTOR You Know
Join Lauren Richey, PGY2 Solid Organ Transplant Pharmacy Resident at UCSF, as she reviews CMV prevention strategies in high-risk liver transplant recipients. This episode highlights the CAPSAL trial comparing antiviral prophylaxis and preemptive therapy in CMV D+/R− recipients, reviews key updates from the 2025 International CMV Consensus Guidelines, and discusses practical implications for transplant pharmacy practice.
114 Folgen
Kommentare
0Sei die erste Person, die kommentiert
Melde dich jetzt an und werde Teil der The mTOR You Know-Community!